Lipid accumulation product is a predictor of nonalcoholic fatty liver disease in childhood obesity
Bahar Özcabı (Özcabı B), Salih Demirhan (Demirhan S), Mesut Akyol (Akyol M), Hatice Öztürkmen Akay (Öztürkmen Akay H), Ayla Güven (Güven A)
Clin Exp Pediatr. 2019;62(12):450-455. Published online 2019 Oct 28 DOI: https://doi.org/10.3345/kjp.2019.00248
|
Citations to this article as recorded by
Risk Stratification of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: Steatohepatitis, Fibrosis, and Hepatocellular Carcinoma
Mohamed El-Kassas, Heba A. Othman, Mohamed Elbadry, Khalid Alswat, Yusuf Yilmaz
Journal of Clinical and Experimental Hepatology.2024; : 102415. CrossRef Lipid Accumulation Product is a Valid Predictor of Hepatic Steatosis and Nonalcoholic Fatty Liver Disease
Qiaoli Huang, Xuying Tan, Qiongmei Wu, Hanqing Zhao, Hangjun Chen, Xinxue Yu, Jinting Wang, Xueyi Huang, Yurong Huang, Jun Wei, Feng Wu, Huilian Zhu, Lijun Wang
Biomarkers in Medicine.2024; 18(3): 123. CrossRef Cardiometabolic Risk Assessment in a Cohort of Children and Adolescents Diagnosed with Hyperinsulinemia
Giorgio Sodero, Donato Rigante, Lucia Celeste Pane, Linda Sessa, Ludovica Quarta, Marcello Candelli, Clelia Cipolla
Diseases.2024; 12(6): 119. CrossRef Evaluation of the ability of insulin resistance and lipid-related indices to predict the presence of NAFLD in obese adolescents
Aylin Yetim, Memduh Şahin, İbrahim Kandemir, Betül Bulakçı, Melike Tuğrul Aksakal, Edanur Karapınar, Hayrettin Sever, Firdevs Baş
Lipids in Health and Disease.2024;[Epub] CrossRef Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6–14 years in China and its applications in high-obesity-risk countries and regions
Yunfei Liu, Youxin Wang, Yunfei Xing, Maike Wolters, Di Shi, Pingping Zhang, Jiajia Dang, Ziyue Chen, Shan Cai, Yaqi Wang, Jieyu Liu, Xinxin Wang, Haoyu Zhou, Miao Xu, Lipo Guo, Yuanyuan Li, Jieyun Song, Jing Li, Yanhui Dong, Yanchun Cui, Peijin Hu, Antje
The Lancet Regional Health - Western Pacific.2024; 49: 101150. CrossRef Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
Xunzhe Yin, Xiangyu Guo, Zuojia Liu, Jin Wang
International Journal of Molecular Sciences.2023; 24(3): 2844. CrossRef Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang
Yanbo Guo, Yunhua Hu, Jing Yang, Rulin Ma, Xianghui Zhang, Heng Guo, Xinping Wang, Yu Li, Xinyu Peng, Shijie Zhang, Jia He, Shuxia Guo
European Journal of Medical Research.2023;[Epub] CrossRef MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón
Frontiers in Medicine.2022;[Epub] CrossRef Single Point Insulin Sensitivity Estimator in Pediatric Non-Alcoholic Fatty Liver Disease
Dieter Furthner, Christian-Heinz Anderwald, Peter Bergsten, Anders Forslund, Joel Kullberg, Håkan Ahlström, Hannes Manell, Iris Ciba, Harald Mangge, Katharina Maruszczak, Pia Koren, Sebastian Schütz, Susanne Maria Brunner, Anna Maria Schneider, Daniel Weg
Frontiers in Endocrinology.2022;[Epub] CrossRef Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity
Xuelian Zhou, Xiufu Lin, Jingnan Chen, Jiaqi Pu, Wei Wu, Zhaoyuan Wu, Hu Lin, Ke Huang, Li Zhang, Yangli Dai, Yan Ni, Guanping Dong, Junfen Fu
Frontiers in Endocrinology.2022;[Epub] CrossRef Lipid Accumulation Product Index Predicts New-Onset Type 2 Diabetes Among Non-Obese Koreans: A 12-Year Longitudinal Study
Seung Ho Yang, Jihyun Yoon, Yong-Jae Lee, Byoungjin Park, Dong-Hyuk Jung
Diabetes, Metabolic Syndrome and Obesity: Targets .2022; Volume 15: 3729. CrossRef Gender Differences in the Relationships among Metabolic Syndrome and Various Obesity-Related Indices with Nonalcoholic Fatty Liver Disease in a Taiwanese Population
I-Ting Lin, Mei-Yueh Lee, Chih-Wen Wang, Da-Wei Wu, Szu-Chia Chen
International Journal of Environmental Research an.2021; 18(3): 857. CrossRef Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
Raquel Cano, José Pérez, Lissé Dávila, Ángel Ortega, Yosselin Gómez, Nereida Valero-Cedeño, Heliana Parra, Alexander Manzano, Teresa Véliz Castro, María Albornoz, Gabriel Cano, Joselyn Rojas-Quintero, Maricarmen Chacín, Valmore Bermúdez
International Journal of Molecular Sciences.2021; 22(9): 4807. CrossRef Cardiovascular Risk Factors and Subclinical Atherosclerosis in Greek Adolescents with Polycystic Ovary Syndrome: Its Relationship with Body Mass Index
Anastasia Garoufi, Athanasia Pagoni, Maria Papadaki, Antonios Marmarinos, Georgios Karapostolakis, Lina Michala, Alexandra Soldatou
Children.2021; 9(1): 4. CrossRef
|